Investigating how reducing Glut1 can prevent diabetes-related complications
Glut1 and the microvascular complications of diabetes
This study is looking at whether reducing a protein called Glut1 can help prevent serious problems that can happen with diabetes, like eye, kidney, and nerve issues, using mice with both Type 1 and Type 2 diabetes to find better ways to manage the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louis Stokes Cleveland VA Medical Center NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11098449 on NIH RePORTER |
What this research studies
This research aims to explore whether lowering the levels of the glucose transporter Glut1 can help prevent serious complications associated with diabetes, such as diabetic retinopathy, kidney disease, and peripheral neuropathy. The study will utilize mouse models of both Type 1 and Type 2 diabetes to assess the effects of Glut1 reduction through genetic and pharmacological methods. By understanding the role of Glut1 in these complications, the research seeks to identify new strategies to improve diabetes management and patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Type 1 or Type 2 diabetes who are at risk for microvascular complications.
Not a fit: Patients without diabetes or those who do not have risk factors for microvascular complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce the risk of severe complications in diabetes patients.
How similar studies have performed: Previous research has shown promising results in targeting Glut1 for preventing diabetic complications, indicating potential for success in this approach.
Where this research is happening
Cleveland, United States
- Louis Stokes Cleveland VA Medical Center — Cleveland, United States (Active)
Researchers
- Principal investigator: Samuels, Ivy S — Louis Stokes Cleveland VA Medical Center
- Study coordinator: Samuels, Ivy S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.